Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene

Muthu Periasamy, Thomas D. Reed, Lynne H. Liu, Yong Ji, Evgeny Loukianov, Richard J. Paul, Michelle L. Nieman, Tara Riddle, John J. Duffy, Thomas C Doetschman, John N. Lorenz, Gary E. Shull

Research output: Contribution to journalArticle

196 Citations (Scopus)

Abstract

The sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene encodes both SERCA2a, the cardiac sarcoplasmic reticulum Ca2+ pump, and SERCA2b, which is expressed in all tissues. To gain a better understanding of the physiological functions of SERCA2, we used gene targeting to develop a mouse in which the promoter and 5' end of the gene were eliminated. Mating of heterozygous mutant mice yielded wild-type and heterozygous offspring; homozygous mutants were not observed. RNase protection, Western blotting, and biochemical analysis of heart samples showed that SERCA2 mRNA was reduced by ~45% in heterozygous mutant hearts and that SERCA2 protein and maximal velocity of Ca2+ uptake into the sarcoplasmic reticulum were reduced by ~35%. Measurements of cardiovascular performance via transducers in the left ventricle and right femoral artery of the anesthetized mouse revealed reductions in mean arterial pressure, systolic ventricular pressure, and the absolute values of both positive and negative dP/dt in heterozygous mutants. These results demonstrate that two functional copies of the SERCA2 gene are required to maintain normal levels of SERCA2 mRNA, protein, and Ca2+ sequestering activity, and that the deficit in Ca2+ sequestering activity due to the loss of one copy of the SERCA2 gene impairs cardiac contractility and relaxation.

Original languageEnglish (US)
Pages (from-to)2556-2562
Number of pages7
JournalJournal of Biological Chemistry
Volume274
Issue number4
DOIs
StatePublished - Jan 22 1999
Externally publishedYes

Fingerprint

Reticulum
Calcium-Transporting ATPases
Protein Isoforms
Genes
Mutation
RNA Isoforms
Sarcoplasmic Reticulum
Messenger RNA
Gene Targeting
Ventricular Pressure
Femoral Artery
Ribonucleases
Transducers
Heart Ventricles
Arterial Pressure
Proteins
Western Blotting
Pumps
Tissue
Blood Pressure

ASJC Scopus subject areas

  • Biochemistry

Cite this

Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. / Periasamy, Muthu; Reed, Thomas D.; Liu, Lynne H.; Ji, Yong; Loukianov, Evgeny; Paul, Richard J.; Nieman, Michelle L.; Riddle, Tara; Duffy, John J.; Doetschman, Thomas C; Lorenz, John N.; Shull, Gary E.

In: Journal of Biological Chemistry, Vol. 274, No. 4, 22.01.1999, p. 2556-2562.

Research output: Contribution to journalArticle

Periasamy, M, Reed, TD, Liu, LH, Ji, Y, Loukianov, E, Paul, RJ, Nieman, ML, Riddle, T, Duffy, JJ, Doetschman, TC, Lorenz, JN & Shull, GE 1999, 'Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene', Journal of Biological Chemistry, vol. 274, no. 4, pp. 2556-2562. https://doi.org/10.1074/jbc.274.4.2556
Periasamy, Muthu ; Reed, Thomas D. ; Liu, Lynne H. ; Ji, Yong ; Loukianov, Evgeny ; Paul, Richard J. ; Nieman, Michelle L. ; Riddle, Tara ; Duffy, John J. ; Doetschman, Thomas C ; Lorenz, John N. ; Shull, Gary E. / Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 4. pp. 2556-2562.
@article{0dddaca4526f4bf198da9193c44d7861,
title = "Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene",
abstract = "The sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene encodes both SERCA2a, the cardiac sarcoplasmic reticulum Ca2+ pump, and SERCA2b, which is expressed in all tissues. To gain a better understanding of the physiological functions of SERCA2, we used gene targeting to develop a mouse in which the promoter and 5' end of the gene were eliminated. Mating of heterozygous mutant mice yielded wild-type and heterozygous offspring; homozygous mutants were not observed. RNase protection, Western blotting, and biochemical analysis of heart samples showed that SERCA2 mRNA was reduced by ~45{\%} in heterozygous mutant hearts and that SERCA2 protein and maximal velocity of Ca2+ uptake into the sarcoplasmic reticulum were reduced by ~35{\%}. Measurements of cardiovascular performance via transducers in the left ventricle and right femoral artery of the anesthetized mouse revealed reductions in mean arterial pressure, systolic ventricular pressure, and the absolute values of both positive and negative dP/dt in heterozygous mutants. These results demonstrate that two functional copies of the SERCA2 gene are required to maintain normal levels of SERCA2 mRNA, protein, and Ca2+ sequestering activity, and that the deficit in Ca2+ sequestering activity due to the loss of one copy of the SERCA2 gene impairs cardiac contractility and relaxation.",
author = "Muthu Periasamy and Reed, {Thomas D.} and Liu, {Lynne H.} and Yong Ji and Evgeny Loukianov and Paul, {Richard J.} and Nieman, {Michelle L.} and Tara Riddle and Duffy, {John J.} and Doetschman, {Thomas C} and Lorenz, {John N.} and Shull, {Gary E.}",
year = "1999",
month = "1",
day = "22",
doi = "10.1074/jbc.274.4.2556",
language = "English (US)",
volume = "274",
pages = "2556--2562",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene

AU - Periasamy, Muthu

AU - Reed, Thomas D.

AU - Liu, Lynne H.

AU - Ji, Yong

AU - Loukianov, Evgeny

AU - Paul, Richard J.

AU - Nieman, Michelle L.

AU - Riddle, Tara

AU - Duffy, John J.

AU - Doetschman, Thomas C

AU - Lorenz, John N.

AU - Shull, Gary E.

PY - 1999/1/22

Y1 - 1999/1/22

N2 - The sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene encodes both SERCA2a, the cardiac sarcoplasmic reticulum Ca2+ pump, and SERCA2b, which is expressed in all tissues. To gain a better understanding of the physiological functions of SERCA2, we used gene targeting to develop a mouse in which the promoter and 5' end of the gene were eliminated. Mating of heterozygous mutant mice yielded wild-type and heterozygous offspring; homozygous mutants were not observed. RNase protection, Western blotting, and biochemical analysis of heart samples showed that SERCA2 mRNA was reduced by ~45% in heterozygous mutant hearts and that SERCA2 protein and maximal velocity of Ca2+ uptake into the sarcoplasmic reticulum were reduced by ~35%. Measurements of cardiovascular performance via transducers in the left ventricle and right femoral artery of the anesthetized mouse revealed reductions in mean arterial pressure, systolic ventricular pressure, and the absolute values of both positive and negative dP/dt in heterozygous mutants. These results demonstrate that two functional copies of the SERCA2 gene are required to maintain normal levels of SERCA2 mRNA, protein, and Ca2+ sequestering activity, and that the deficit in Ca2+ sequestering activity due to the loss of one copy of the SERCA2 gene impairs cardiac contractility and relaxation.

AB - The sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene encodes both SERCA2a, the cardiac sarcoplasmic reticulum Ca2+ pump, and SERCA2b, which is expressed in all tissues. To gain a better understanding of the physiological functions of SERCA2, we used gene targeting to develop a mouse in which the promoter and 5' end of the gene were eliminated. Mating of heterozygous mutant mice yielded wild-type and heterozygous offspring; homozygous mutants were not observed. RNase protection, Western blotting, and biochemical analysis of heart samples showed that SERCA2 mRNA was reduced by ~45% in heterozygous mutant hearts and that SERCA2 protein and maximal velocity of Ca2+ uptake into the sarcoplasmic reticulum were reduced by ~35%. Measurements of cardiovascular performance via transducers in the left ventricle and right femoral artery of the anesthetized mouse revealed reductions in mean arterial pressure, systolic ventricular pressure, and the absolute values of both positive and negative dP/dt in heterozygous mutants. These results demonstrate that two functional copies of the SERCA2 gene are required to maintain normal levels of SERCA2 mRNA, protein, and Ca2+ sequestering activity, and that the deficit in Ca2+ sequestering activity due to the loss of one copy of the SERCA2 gene impairs cardiac contractility and relaxation.

UR - http://www.scopus.com/inward/record.url?scp=0033593328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033593328&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.4.2556

DO - 10.1074/jbc.274.4.2556

M3 - Article

C2 - 9891028

AN - SCOPUS:0033593328

VL - 274

SP - 2556

EP - 2562

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -